Epilepsy Study Consortium Inc. Logo

MIP Score

62

Health Associations
Epilepsy Care

Epilepsy Study Consortium Inc.

Mission

The Epilepsy Study Consortium is a collaborative group of scientific investigators from leading academic medical research centers focused on reducing the time it takes to bring effective therapies to patients with epilepsy. They work across various fields to enhance clinical trial methodologies, foster partnerships with industry and regulatory bodies, and streamline the research process to improve treatment outcomes.

Basic Information

Tax-Exempt

Address

2325 Dulles Corner Blvd, Herndon, Virginia, 20171

View all Herndon charities

Founded in

2006

EIN

20-4950952

Total Assets

$1.784 million

UN Sustainable Development Goals Supported

This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

Showing 2 of 2 goals

At a Glance

Who We Are

Who We Are

An introduction to the Epilepsy Study Consortium and its members.

ETDD Symposium

ETDD Symposium

A biennial symposium focused on advancing epilepsy therapies and diagnostics.

Collaborative Research

Collaborative Research

The importance of collaborative research in advancing new epilepsy therapies.

Impact Stats

100+

Number of Trials

Clinical Trials Conducted

Assisted with the design and conduct of more than 100 clinical trials since 2007.

8

Number of New Therapies

New Therapies Approved

Successfully brought 8 new anti-epileptic drugs and devices to market.

Upcoming Events

Epilepsy Therapies & Diagnostics Development XVIII Symposium

Epilepsy Therapies & Diagnostics Development XVIII Symposium

May 28-30, 2025

A symposium discussing new epilepsy therapies and diagnostics, aimed at expediting their development.

Learn More

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

62

54

/100

Program Expense Ratio

97.65%

20

/20

Program Revenue Growth

105.97%

20

/20

Leverage Ratio

0

2

/20

Working Capital Ratio

0.9301

10

/20

Fundraising Efficiency

0

2

/20

Latest Filing Data: Form 990

Fiscal Year:2022

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants621.7K29.21%
Program Services1.507M70.79%
Investment Income330.00%
Sales of Non-Inventory Assets00.00%
Other Notable Sources00.00%
Total Revenue2.128M100.00%